| Appearance | Pale yellow solid powder |
| Assay | 99.87% |
| Water Content(KF) | ≤ 1.00% |
| Melting Point | 176.0°C – 182.0°C |
| Heavy Metals | ≤ 20ppm |
| Residue on Ignition | ≤ 0.20% |
| Solubility | Soluble in DMSO; Slightly Soluble in Dimethylformide; Sparingly Soluble in 0.1 N HCl, Methylene Chloride;
Practically Insoluble in Water,Hexane, 0.1 N NaOH |
Paliperidone
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, 9-Hydroxyrisperido
| Purity / Analysis Method | 98.0% – 102.0% |
| Molecular Formula / Molecular Weight | C23H27FN4O3 = 426.49 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 144598-75-4 |
| Unit | Price |
| 1 g | 7500 |
| 5 g | 9500 |
| 10 g | 16000 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
